[Cabergolin: new horizons in the therapy of Parkinson diseases].
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D018491:Dopamine Agonists; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012148:Restless Legs Syndrome / Q000188:drug therapy
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline
Cabergolin: Neue Horizonte in der Therapie des Morbus Parkinson.